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ABSTRACT
Background: Availability of safe blood and blood products for transfusion is increasingly 
difficult globally, especially in developing countries because of high prevalence of 
Transfusion Transmissible Infections. 
Objectives:  To determine the prevalence of HBsAg among blood donors and to evaluate 
the socio-economic, demographic and medical factors associated with its infection.
Design: A prospective study.
Subjects: Three hundred and fifty consecutive blood donors were recruited. 2 ml of 
venous blood was collected aseptically from the ante-cubital vein and subjected to 
serological test for HBsAg.
Results: High prevalence rate 10.9% was recorded. All the donors reactive to HBsAg 
were males (38,100%) with a mean age of 30.7±8.02 years, while 55.3%,  44.7%, 5.3%, 
42%, 47.4%, 5.3% of them were single, married, primary school graduate, secondary 
school graduate, tertiary school graduate and illiterate respectively with 36.8%, 23.7%, 
39.5% and 0% been unemployed, civil servants/professionals, skilled artisans and 
business/petty traders. The most common risk factor was multiple sexual partners 55.3%, 
followed by extra marital affairs 13.2%, tattooing 10.5%, previous blood transfusion 
5.2%, previous surgery 2.6% and sex trading 2.6%.
Conclusion: Active public enlightenment programmes and strict blood donation 
selection criteria need to be put in place in order to provide safe blood and blood 
products for transfusion.
INTRODUCTION
Transfusion Transmissible Infections (TTIs) are still 
major concerns in blood transfusion medicine in 
Nigeria and the world over making the practice 
of safe blood transfusion increasingly difficult. 
Hepatitis B virus is one of the serious infectious risks 
of blood transfusion all over the world and it is one 
of the most potent causes of viral Hepatitis, an acute 
inflammation of liver caused by Hepatitis viruses. Of 
all the hepatotrophic viruses, hepatitis B is a major 
public health problem in developing countries (1) 
and worldwide. It is the most serious viral hepatitis, 
leading to liver cirrhosis and liver cancer in chronic 
consequences.
 Globally, an estimated two billion people have 
been infected with hepatitis B virus (HBV) (2), with the 
world carrier rate of about 350 million (3). Hepatitis B 
is hyper-endemic in sub-Saharan Africa and Asia (4,5). 
Infections with Hepatitis B virus have been associated 
with long-term morbidity and mortality due to 
complications like cirrhosis, portal hypertension, 
chronic liver diseases and hepatocellular carcinoma 
(6).
 About one million people die annually from 
HBV related Chronic Liver Diseases (7). The virus is 
transmitted parenterally mainly through blood and 
blood products transfusions, sexual contact, injuries 
with contaminated sharp objects like needles, and 
blades, sharing of needles as with drug addicts and 
vertical transmission from mother to foetus (8).
 The complete Hepatitis B virus, about 42 nmm 
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in diameter, is a double stranded DNA spherical 
particle with a double shell. Hepatitis B surface 
antigen (HBsAg), Hepatitis B core antigen (HBcAg) 
and Hepatitis B e antigen (HBeAg) are the three forms 
of antigens associated with hepatitis B infection. The 
levels of all the three antigens rise during infection. 
HBsAg level remains high both in acute and chronic 
phases of hepatitis B virus infection.   
 Infection with HBV is diagnosed by the detection 
of HBsAg in the blood of the patient. Screening for 
TTIs including HBV in the donor(s) is done routinely 
in all blood banks to detect HBV infection. Any donor 
found reactive or positive to HBV and other TTIs are 
permanently deferred for blood donation. 
 The high prevalence rates of HBsAg quoted from 
some parts of this country among blood donors are 
still worrisome (9,10). A very wide prevalence range 
of 0.66-25% of HBsAg among blood donors have 
been reported from different parts of the world (11). 
In Nigeria, prevalence range is 6-8.4% (12-15). 
 Prevalence of HBV among blood donors in this 
centre and the entire north central zone of Nigeria has 
not been studied in the past five years. We therefore 
decided to study the prevalence and the risk factors of 
hepatitis B surface antigen among our blood donors 
in Ilorin.
MATERIALS AND METHODS
Three hundred and fifty (350) consecutive blood 
donors who consented to participate in this study 
were recruited at the blood bank of the University of 
Ilorin Teaching Hospital. Hospital ethical approvals 
as well as informed consent from subjects were 
obtained before commencement of this study. The 
socio-demographic characteristics and information 
on risk factors of participants were collected using 
structured questionnaires specifically designed for 
this purpose.
 Two millilitres of venous blood was collected 
aseptically from the ante-cubital vein of each 
subject and put in an EDTA bottle. The sample was 
centrifuged at 1500 revolutions/minutes and the 
serum collected into a plain bottle and stored at -20ºc 
until analysed.
 HBsAg testing was done using a one stage 
Hepatitis B surface antigen test strip, a qualitative 
lateral flow immuno-assay kit Grand Medical 
Diagnostic, USA according to manufacturer ’s 
instruction.
Data analysis: The mean, frequencies and standard 
deviation were analysed using SPSS version 2.0. 
RESULTS
The overall prevalence of HBsAg among our blood 
donors was 10.9% (38 out of 350 blood donors). Table 
1, Figures 1 and 2 summarise the demographic, socio-
economic and risk factors in all the donors (38 HBsAg 
reactive and 312 HBsAg non reactive donors)
Table 1
Demographic Pattern, Socio-economic and Risk Factors for Hepatitis Amongst the HBsAg Reactive and Non 
reactive Donors














N/% N/% N/% N/%
Total Number 38(10.9) 312(89.1) 38(10.9) 312(89.1)
Mean Age 30.76±8.02 31.41±8.33 30.76±8.02 31.41±8.33
Sex: Tattooing 4(10.5) 30(9.6)
Male 38(100) 301(96.5)
Female 0(0) 11(3.5)




















Skilled artisans 15(39.5) 73(23.4)
Business/petty trading 0(0) 40(12.8)






Sex trading 1(2.6) 0(0)
Homosexualism 0(0) 6(1.9)
Oral sex 0(0) 6(1.9)
Anal sex/STI 0(0)/ 0(0) 3(1.0)/2(0.6)
Figure 1
Demography of HBsAg reactive and non reactive donors
Figure 2
Risk factors for Hepatitis in HBsAg non reactive and reactive donors
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Three hundred and fifty blood donors (339 males 
and 11 females) aged 31.41±8.33 years (mean± SD) 
were recruited to the study. Thirty eight (10.9%) 
were reactive while 312 (89.1%) were non-reactive to 
HBsAg. All the donors reactive to HBsAg were males 
(38,100%) while 21 (55.3%), 17 (44.7%), 2 (5.3%), 16 
(42%), 18 (47.4%) and 2 (5.3%) were single, married, 
primary school graduate, secondary school graduate, 
tertiary school graduate and illiterate respectively 
with 14(36.8%), 9 (23.7%), 15 (39.5% and 0 (0%) been 
unemployed, civil servants/professionals, skilled 
artisans and business/petty traders. Concerning the 
risk factors amongst the reactive donors, multiple 
sexual partners (>1) was the highest 21 (55.3%) 
followed by extra marital affairs 5 (13.2%), tattooing 4 
(10.5%), previous blood transfusion 2 (5.2%), previous 
surgery 1 (2.6%) and sex trading 1 (2.6%). None of 
them was involved in homosexualism, oral sex, anal 
sex and sexually transmitted infections.
 For the HBsAg non-reactive donors, 301 
(96.5%) were males while 11 (3.5%) were females. 
One hundred and twenty one (38.8%), 189 (60.65), 
2 (0.6%), 19 (6.1%), 103 (34%), 167 (53.5%), 13 (4.25) 
and 6 (1.9%) were single, married, widowed, primary 
school graduates, secondary school graduates, tertiary 
institution graduates, illiterates and others with 102 
(32.7%), 97 (31.1%), 73 (23.4%) and 40 (12.8%) were 
unemployed, civil servants/professionals, skilled 
artisans and business men/petty traders respectively. 
The risk factors amongst the non-reactive donors were 
30 (9.6%), 12(3.85), 11 (3.5%), 42 (13.5%), 18 (5.8%), 
100 (32.1%), 0 (0%), 6 (1.9%), 6 (1.9%), 3 (1.0%) and 
2 (0.6%) for tattooing, previous surgery, previous 
blood transfusion, multiple sexual partners, positivity 
to other TTIs, extra marital affairs, sex trading, 
homosexualism, oral sex, anal sex and sexually 
transmitted infections.
DISCUSSION
A high seroprevalence rate of 10.9% was recorded in 
this study for HBsAg. This is in keeping with WHO 
report of Hepatitis B virus infection endemicity in this 
environment (16). The prevalence rate in this centre 
is similar to that found in other parts of the country, 
10.6% in the South-South region of Nigeria (9) and 
13.2% in Ibadan, south-west region of Nigeria (10). In 
some other parts of the country very low prevalence 
rate have been reported, 1.1% in the Niger Delta region 
(18), 1.2% in North-Easter region of Nigeria (19) and, 
2.4% among voluntary blood donors in Yola (20). 
Outside Nigeria, the prevalence ranges from 2.2% 
among Pakistani blood donors (21) and 10% among 
Sudanese blood donors (17). 
 Prevalence of HBsAg among voluntary blood 
donors is lower than that among blood donors 
generally. Most of the reported cases of lower 
prevalence quoted above were among voluntary 
blood donors. 
 The mean age of all the donors was 31.41±8.33 
years, and they are predominantly males. This is 
similar to the findings by other researchers (13,19). 
Majority of the blood donors were unemployed 116 
(33.1%). The major risk factor among our donors 
found reactive to HBsAg was multiple sexual 
partners, which constituted the highest in the study, 
21 (55.3%). This was followed by extra marital 
affairs 5 (13.2%), tattooing 4 (10.5%), previous blood 
transfusion 2 (5.2%), previous surgery 1 (2.6%) and 
history of sex trading 1 (2.6%). This is similar to 
the findings of other researchers. In a study among 
Egyptian blood donors, 50 and 4% of the positive 
cases had multiple sexual partners and history of 
blood transfusion respectively (22). In a similar study 
in Bangladesh HBV-seropositivity was found to be 
significantly associated with married status, history 
of jaundice, surgical operations, needle-stick injuries, 
visiting unregistered health-care providers, receiving 
treatment for sexually transmitted diseases, animal 
bites, ear-nose-body piercing in females, circumcision 
and visiting community barber for shaving in males 
(23). 
 Because of the high prevalence of HBsAg in 
this study, getting safe blood for transfusion will be 
difficult in this environment.
LIMITATION
The finding of high seroprevalence rate was based 
on the reactivity of the samples to Hepatitis B 
surface antigen rapid test strip used for the study. A 
confirmation of the infection is necessary with the use 
of Polymerase Chain Reaction, which is not available 
in our centre. It is possible that the real prevalence 
rate may not be as high as was found in the study.
RECCOMENDATION
Accurate donor selection and the decision to accept a 
blood donation is centred on the safety of the person 
donating the blood and the safety of the individual 
receiving the blood and its components (24).
 Because of the findings of high prevalence of 
Hepatitis B virus reactivity amongst blood donors 
in this environment, the associated behaviour-, 
medically- and socio-economically- related risk 
factors, there is need for very strict blood donor 
selection criteria, like the one outlined by Australian 
Red Cross Blood Service (24), as well as the use of very 
specific and sensitive screening method for Hepatitis 
B in the donated blood units before transfusion. A 
continuous educational programme on the mode of 
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transmission and probably the effects of Hepatitis B 
virus is advised both for the public and also for all 
type of donors, even for those already in the Voluntary 
Non Remunerated Blood Donor (VNRBD) pool. 
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